Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
512 SEK | +0.39% |
|
+22.78% | +55.39% |
07-12 | Transcript : Xvivo Perfusion AB, Q2 2024 Earnings Call, Jul 12, 2024 | |
07-12 | Xvivo Perfusion AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.39% | 1.52B | |
-6.68% | 179B | |
-5.20% | 100B | |
-5.38% | 66.67B | |
+18.33% | 44.81B | |
-6.47% | 46.16B | |
+9.74% | 44.38B | |
+14.01% | 29.53B | |
+21.25% | 25.83B | |
-6.53% | 23.97B |
- Stock Market
- Equities
- XVIVO Stock
- News Xvivo Perfusion AB
- Transcript : Xvivo Perfusion AB, Q2 2024 Earnings Call, Jul 12, 2024